A Zeevi
Overview
Explore the profile of A Zeevi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
255
Citations
3128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ellison M, Mangiola M, Marrari M, Bentlejewski C, Sadowski J, Zern D, et al.
Front Immunol
. 2023 Mar;
14:1110292.
PMID: 36999035
Human leukocyte antigen (HLA) molecular mismatch is a powerful biomarker of rejection. Few studies have explored its use in assessing rejection risk in heart transplant recipients. We tested the hypothesis...
2.
Sharma M, Webber S, Zeevi A, Mohanakumar T
Hum Immunol
. 2019 Feb;
80(4):248-256.
PMID: 30710563
Antibodies to HLA resulting in positive cytotoxicity crossmatch are generally considered a contraindication for cardiac transplantation. However, cardiac transplantations have been performed in children by reducing the Abs and modifying...
3.
Roux A, Levine D, Zeevi A, Hachem R, Halloran K, Halloran P, et al.
Am J Transplant
. 2018 Jun;
19(1):21-31.
PMID: 29956477
The Lung session of the 2017 14th Banff Foundation for Allograft Pathology Conference, Barcelona focused on the multiple aspects of antibody-mediated rejection (AMR) in lung transplantation. Multidimensional approaches for AMR...
4.
Webber S, Zeevi A, Mason K, Addonizio L, Blume E, Dipchand A, et al.
Am J Transplant
. 2018 Apr;
18(9):2148-2162.
PMID: 29673058
Sensitization is common in pediatric heart transplant candidates and waitlist mortality is high. Transplantation across a positive crossmatch may reduce wait time, but is considered high risk. We prospectively recruited...
5.
Stevenson H, Prats M, Isse K, Zeevi A, Avitzur Y, Ng V, et al.
Am J Transplant
. 2018 Feb;
18(6):1534-1543.
PMID: 29464837
According to the Banff criteria for kidney allografts, isolated vascular or "v" lesions are defined as intimal inflammation, age-inappropriate fibro-intimal hyperplasia, or both, without the presence of associated interstitial T...
6.
Dipchand A, Webber S, Mason K, Feingold B, Bentlejewski C, Mahle W, et al.
Am J Transplant
. 2018 Feb;
18(9):2163-2174.
PMID: 29442424
Data on the clinical importance of newly detected donor-specific anti-HLA antibodies (ndDSAs) after pediatric heart transplantation are lacking despite mounting evidence of the detrimental effect of de novo DSAs in...
7.
Ensor C, Yousem S, Marrari M, Morrell M, Mangiola M, Pilewski J, et al.
Am J Transplant
. 2017 Feb;
17(5):1380-1388.
PMID: 28173620
We present this observational study of lung transplant recipients (LTR) treated with carfilzomib (CFZ)-based therapy for antibody-mediated rejection (AMR) of the lung. Patients were considered responders to CFZ if complement-1q...
8.
Lefaucheur C, Viglietti D, Mangiola M, Loupy A, Zeevi A
J Immunol Res
. 2017 Jan;
2017:5201098.
PMID: 28133619
The purpose of the present review is to describe how we improve the model for risk stratification of transplant outcomes in kidney transplantation by incorporating the novel insights of donor-specific...
9.
Green D, Brooks M, Burckart G, Chinnock R, Canter C, Addonizio L, et al.
Am J Transplant
. 2016 Dec;
17(6):1525-1539.
PMID: 27931092
Significant racial disparity remains in the incidence of unfavorable outcomes following heart transplantation. We sought to determine which pediatric posttransplantation outcomes differ by race and whether these can be explained...
10.
Bruneval P, Angelini A, Miller D, Potena L, Loupy A, Zeevi A, et al.
Am J Transplant
. 2016 Nov;
17(1):42-53.
PMID: 27862968
The 13th Banff Conference on Allograft Pathology was held in Vancouver, British Columbia, Canada from October 5 to 10, 2015. The cardiac session was devoted to current diagnostic issues in...